Cite

HARVARD Citation

    Zhu, K. et al. (2018). Excellent real‐world outcomes of adults with Burkitt lymphoma treated with CODOX‐M/IVAC plus or minus rituximab. British journal of haematology. pp. 782-790. [Online]. 
  
Back to record